338 related articles for article (PubMed ID: 17896619)
1. Prolonged somatostatin therapy may cause down-regulation of SSTR-like GPCRs on Schistosoma mansoni.
Chatterjee S; Op De Beeck J; Rao AV; Desai DV; Vrolix G; Rylant F; Panis T; Bernat A; Van Bergen J; Peeters D; Van Marck E
J Vector Borne Dis; 2007 Sep; 44(3):164-80. PubMed ID: 17896619
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic effect of the neuropeptide hormone somatostatin on Schistosoma mansoni caused liver fibrosis.
Chatterjee S; Vrolix G; Depoortere I; Peeters T; Van Marck E
BMC Infect Dis; 2005 Jun; 5():45. PubMed ID: 15949036
[TBL] [Abstract][Full Text] [Related]
3. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.
Van Nassauw L; Toovey S; Van Op den Bosch J; Timmermans JP; Vercruysse J
Travel Med Infect Dis; 2008 Sep; 6(5):253-8. PubMed ID: 18760248
[TBL] [Abstract][Full Text] [Related]
4. Schistosoma: a 200-kDa chemotherapeutic target antigen is differentially localized in African vs Oriental species.
Tanaka TM; Skubitz AP; Strand M
Exp Parasitol; 1993 May; 76(3):293-301. PubMed ID: 7684706
[TBL] [Abstract][Full Text] [Related]
5. Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology.
Xiao SH; Guo J; Chollet J; Wu JT; Tanner M; Utzinger J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):148-53. PubMed ID: 15597709
[TBL] [Abstract][Full Text] [Related]
6. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
[TBL] [Abstract][Full Text] [Related]
8. Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model.
Keiser J; El Ela NA; El Komy E; El Lakkany N; Diab T; Chollet J; Utzinger J; Barakat R
Am J Trop Med Hyg; 2006 Aug; 75(2):287-91. PubMed ID: 16896134
[TBL] [Abstract][Full Text] [Related]
9. Expression of somatostatin and somatostatin receptor subtypes in Apolipoprotein D (ApoD) knockout mouse brain: An immunohistochemical analysis.
Rajput PS; Billova S; Patel SC; Kharmate G; Somvanshi RK; Kumar U
J Chem Neuroanat; 2009 Sep; 38(1):20-33. PubMed ID: 19465111
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
Allam G
Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
[TBL] [Abstract][Full Text] [Related]
11. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
12. Validation of sensitivity to praziquantel using Schistosoma mansoni worm muscle tension and Ca2+-uptake as possible in vitro correlates to in vivo ED50 determination.
William S; Botros S
Int J Parasitol; 2004 Jul; 34(8):971-7. PubMed ID: 15217736
[TBL] [Abstract][Full Text] [Related]
13. Host-parasite relationships in infections with two Kenyan isolates of Schistosoma mansoni in NMRI mice.
Thiongo FW; Madsen H; Ouma JH; Andreassen J; Christensen NO
J Parasitol; 1997 Apr; 83(2):330-2. PubMed ID: 9105324
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the anthelmintic effects of artesunate against experimental Schistosoma mansoni infection in mice using different treatment protocols.
Shaohong L; Kumagai T; Qinghua A; Xiaolan Y; Ohmae H; Yabu Y; Siwen L; Liyong W; Maruyama H; Ohta N
Parasitol Int; 2006 Mar; 55(1):63-8. PubMed ID: 16290045
[TBL] [Abstract][Full Text] [Related]
15. Serodiagnosis of Schistosoma mansoni infections in an endemic area of Burkina Faso: performance of several immunological tests with different parasite antigens.
Sorgho H; Bahgat M; Poda JN; Song W; Kirsten C; Doenhoff MJ; Zongo I; Ouédraogo JB; Ruppel A
Acta Trop; 2005 Feb; 93(2):169-80. PubMed ID: 15652331
[TBL] [Abstract][Full Text] [Related]
16. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response.
Brindley PJ; Sher A
J Immunol; 1987 Jul; 139(1):215-20. PubMed ID: 3108397
[TBL] [Abstract][Full Text] [Related]
17. Repeated infections with Schistosoma mansoni and liver fibrosis in undernourished mice.
Coutinho EM; Silva FL; Barros AF; Araújo RE; Oliveira SA; Luna CF; Barbosa AA; Andrade ZA
Acta Trop; 2007 Jan; 101(1):15-24. PubMed ID: 17194437
[TBL] [Abstract][Full Text] [Related]
18. Increased parasitaemia and delayed parasite clearance in Schistosoma mansoni and Plasmodium berghei co-infected mice.
Legesse M; Erko B; Balcha F
Acta Trop; 2004 Jul; 91(2):161-6. PubMed ID: 15234665
[TBL] [Abstract][Full Text] [Related]
19. Tegumental changes in adult Schistosoma mansoni harbored in mice treated with artemether.
Xiao S; Shen B; Chollet J; Utzinger J; Tanner M
J Parasitol; 2000 Oct; 86(5):1125-32. PubMed ID: 11128492
[TBL] [Abstract][Full Text] [Related]
20. Lack of evidence for an antischistosomal activity of myrrh in experimental animals.
Botros S; William S; Ebeid F; Cioli D; Katz N; Day TA; Bennett JL
Am J Trop Med Hyg; 2004 Aug; 71(2):206-10. PubMed ID: 15306712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
